Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
76.79
-0.08 (-0.10%)
At close: Aug 12, 2026, 4:00 PM EDT
76.78
-0.01 (-0.01%)
After-hours: Aug 12, 2026, 4:47 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $1.88 billion as of August 12, 2026. Its market cap has increased by 1,362.42% in one year.
Market Cap
1.88B
Enterprise Value
1.82B
1-Year Change
1,362.42%
Ranking
Category
Stock Price
$76.79
ChartMarket Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $1.88B, an increase of 934.69%. That is a compound annual growth rate of 46.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 1.88B | 286.06% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.98B |
| Nanobiotix | 1.95B |
| Sarepta Therapeutics | 1.94B |
| Kardigan | 1.92B |
| Damora Therapeutics | 1.92B |
| Generate Biomedicines | 1.88B |
| Lakefront Biotherapeutics NV | 1.86B |
| Syndax Pharmaceuticals | 1.81B |